Jacobs & CO Abbott Laboratories Transaction History

Jacobs & CO

$983 Million
Q4 2024

A detailed history of Jacobs & CO transactions in Abbott Laboratories stock. As of the latest transaction made, Jacobs & CO holds 64,914 shares of ABT stock, worth $7.37 Million. This represents 0.75% of its overall portfolio holdings.

Number of Shares

64,914

Previous 66,756 2.76%

Holding current value

$7.37 Million

Previous $7.61 Million 3.52%

% of portfolio

0.75%

Previous 0.76%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 10, 2025	SELL	$111.93 - $119.39 $206,175 - $219,916	-1,842 Reduced 2.76%	64,914 $7.34 Million
Q3 2024 Oct 01, 2024	SELL	$100.07 - $118.13 $125,687 - $148,371	-1,256 Reduced 1.85%	66,756 $7.61 Million
Q2 2024 Jul 12, 2024	BUY	$100.73 - $112.44 $11,382 - $12,705	113 Added 0.17%	68,012 $7.07 Million
Q1 2024 Apr 12, 2024	SELL	$109.52 - $120.96 $89,915 - $99,308	-821 Reduced 1.19%	67,899 $7.72 Million
Q4 2023 Jan 17, 2024	SELL	$90.19 - $110.4 $51,408 - $62,928	-570 Reduced 0.82%	68,720 $7.56 Million
Q3 2023 Oct 13, 2023	SELL	$95.53 - $114.62 $12,514 - $15,015	-131 Reduced 0.19%	69,290 $6.71 Million
Q2 2023 Jul 11, 2023	SELL	$100.78 - $112.29 $179,892 - $200,437	-1,785 Reduced 2.51%	69,421 $7.57 Million
Q1 2023 Apr 17, 2023	SELL	$96.86 - $114.01 $106,255 - $125,068	-1,097 Reduced 1.52%	71,206 $7.21 Million
Q4 2022 Jan 13, 2023	BUY	$95.06 - $111.52 $29,088 - $34,125	306 Added 0.43%	72,303 $7.94 Million
Q3 2022 Oct 11, 2022	SELL	$96.76 - $112.03 $17,416 - $20,165	-180 Reduced 0.25%	71,997 $6.97 Million
Q2 2022 Jul 19, 2022	SELL	$102.07 - $123.37 $503,613 - $608,707	-4,934 Reduced 6.4%	72,177 $7.84 Million
Q1 2022 Apr 14, 2022	SELL	$114.02 - $139.04 $25,654 - $31,284	-225 Reduced 0.29%	77,111 $9.13 Million
Q4 2021 Jan 21, 2022	SELL	$115.53 - $141.46 $160,586 - $196,629	-1,390 Reduced 1.77%	77,336 $10.9 Million
Q3 2021 Oct 13, 2021	BUY	$116.66 - $129.06 $19,365 - $21,423	166 Added 0.21%	78,726 $9.3 Million
Q2 2021 Jul 15, 2021	SELL	$105.79 - $124.53 $361,272 - $425,269	-3,415 Reduced 4.17%	78,560 $9.11 Million
Q1 2021 Apr 05, 2021	SELL	$108.84 - $128.23 $96,541 - $113,740	-887 Reduced 1.07%	81,975 $9.82 Million
Q4 2020 Jan 12, 2021	SELL	$105.0 - $114.42 $209,160 - $227,924	-1,992 Reduced 2.35%	82,862 $9.07 Million
Q3 2020 Dec 03, 2020	SELL	$91.64 - $111.29 $33,448 - $40,620	-365 Reduced 0.43%	84,854 $9.23 Million
Q2 2020 Jul 09, 2020	SELL	$76.57 - $98.0 $284,304 - $363,874	-3,713 Reduced 4.18%	85,219 $7.79 Million
Q1 2020 Apr 13, 2020	SELL	$62.82 - $91.86 $134,560 - $196,764	-2,142 Reduced 2.35%	88,932 $7.02 Million
Q4 2019 Jan 29, 2020	BUY	$78.51 - $87.4 $256,963 - $286,060	3,273 Added 3.73%	91,074 $7.91 Million
Q3 2019 Nov 04, 2019	SELL	$81.84 - $88.74 $188,477 - $204,368	-2,303 Reduced 2.56%	87,801 $7.35 Million
Q2 2019 Aug 01, 2019	SELL	$72.88 - $85.0 $38,407 - $44,795	-527 Reduced 0.58%	90,104 $7.58 Million
Q1 2019 Apr 29, 2019	SELL	$66.22 - $80.06 $122,507 - $148,111	-1,850 Reduced 2.0%	90,631 $7.25 Million
Q4 2018 Feb 07, 2019	SELL	$65.56 - $74.27 $226,509 - $256,602	-3,455 Reduced 3.6%	92,481 $6.69 Million
Q3 2018 Oct 23, 2018	SELL	$60.81 - $73.36 $148,437 - $179,071	-2,441 Reduced 2.48%	95,936 $7.04 Million
Q2 2018 Jul 19, 2018	SELL	$57.57 - $63.54 $125,214 - $138,199	-2,175 Reduced 2.16%	98,377 $6 Million
Q1 2018 Apr 30, 2018	SELL	$56.27 - $63.62 $88,906 - $100,519	-1,580 Reduced 1.55%	100,552 $6.03 Million
Q4 2017 Feb 09, 2018	SELL	$53.68 - $57.47 $43,749 - $46,838	-815 Reduced 0.79%	102,132 $5.83 Million
Q3 2017 Nov 14, 2017	BUY	$48.06 - $53.64 $4.95 Million - $5.52 Million	102,947	102,947 $5.49 Million

Others Institutions Holding ABT

# of Institutions

3,196

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $199B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs & CO with notifications on news.

Account